The Latest Clinical Articles

What physicians should know about recognizing attacks, finding secondary disease, and knowing when to refer to rheumatology.

Five practical ways to start, without learning to code or leaving clinical practice.

56% of Gen Z respondents reported turning to TikTok for health and wellness information in a 2024 Zing Coach survey. As health information becomes increasingly accessible through social media, so does medical misinformation.

"Is there anything I should eat differently so my cancer does not come back?" It is one of the most common questions patients ask after completing cancer treatment.

"Can I take Ozempic after breast cancer?" It is becoming an increasingly common question in survivorship clinics.

Artificial intelligence (AI) has quickly become one of the most discussed topics in oncology. Every week seems to bring another announcement of a new large language model, imaging algorithm, or prediction that AI will transform cancer care.

Physicians get very good at preparing for things. Boards. Procedures. Difficult cases. The first day of residency. The first day as an attending. Finances do not always get the same advance planning.

You're reviewing a patient's medications. "Anything else you take regularly?" "Just something to help me sleep." Easy enough. "What do you take?" They pause.

The visit is over. You reviewed the diagnosis, talked through the treatment plan, sent the prescription, and asked if there were any questions. "Nope, I think I'm good." Then your patient gets to the pharmacy.

Historically, atopic dermatitis (AD or eczema) was viewed primarily as a chronic inflammatory skin condition. Over the past decade, however, research has revealed that AD is far more than simply dry skin, arising from a complex interaction of genetics, immune dysregulation, skin barrier dysfunction, the skin microbiome, and environmental exposures.

Two patients. One disease. Yet neither patient experiences the disease in the same way.

ASCO 2026 sparked passionate conversations about emerging topics in oncology. DocUpdate CEO Dr. Osama Hashmi joined hosts in a spirited discussion of ASCO's most controversial subjects.